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Introduction
Top1 (topoisomerase I) regulates DNA topology during repli-
cation, transcription, and chromatin remodeling (Champoux, 
2001; Wang, 2002). It removes DNA torsional stress (super-
coiling) by forming cleavage complexes (Top1–DNA cleavage 
complexes [Top1cc’s]) in which one DNA strand is cleaved by 
covalent binding of Top1 to a 3 DNA phosphate. After DNA 
relaxation, Top1cc’s reverse rapidly, and Top1 is released as 
the DNA religates. The plant alkaloid camptothecin (CPT) and 
its clinical derivatives, topotecan and irinotecan, are highly se-
lective Top1 inhibitors that reversibly trap Top1cc by binding at 
the enzyme–DNA interface (Hsiang et al., 1985; Pommier et al., 
2010). At pharmacological concentrations, they kill cancer cells 
in a replication-dependent manner (Holm et al., 1989; Hsiang 
et  al., 1989), as replication forks collide with the stabilized 
Top1cc’s. Such collisions are because Top1cc’s do not reverse 
fast enough ahead of moving replication forks (Pommier et al., 
2006), resulting in DNA double-strand ends (DSEs; Hsiang 
et al., 1989; Strumberg et al., 2000).
The repair of Top1-mediated DNA damage requires both 
the excision of the covalently attached Top1 from the DNA and 
the repair of the DSE resulting from replication. A specialized 
pathway for the excision of Top1cc hinges on TDP1 (tyrosyl-
DNA phosphodiesterase I), an enzyme conserved from yeast to 
humans, which hydrolyzes the covalent bond between Top1 
and the 3 DNA end (Yang et al., 1996; Pouliot et al., 1999; 
Interthal et al., 2005; Dexheimer et al., 2008a). Genetic studies 
also indicate that Top1cc can be repaired by other TDP1- 
independent pathways involving the endonucleases Rad1
XPF-
Rad10
ERCC1 and Mus81-Mms4
EME1 (Liu et al., 2002; Vance and 
Wilson, 2002; Deng et al., 2005; Ciccia et al., 2008; Zhang   
et al., 2011).
Mus81-Eme1 is a heterodimeric endonuclease that acts 
preferentially on DNA substrates mimicking stalled replica-
tion forks and nicked Holliday junctions in vitro (Interthal and 
Heyer, 2000; Fricke et al., 2005; Ciccia et al., 2008; Ehmsen 
and Heyer, 2008). It cleaves such structures in the duplex re-
gion adjacent to the branched point (Ehmsen and Heyer, 2009). 
Mus81-Eme1 has been shown to play a critical role in both 
replication fork rescue and homologous recombination. It 
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eoxyribonucleic acid (DNA) topoisomerases are 
essential for removing the supercoiling that nor-
mally builds up ahead of replication forks. The 
camptothecin (CPT) Top1 (topoisomerase I) inhibitors exert 
their anticancer activity by reversibly trapping Top1–DNA 
cleavage complexes (Top1cc’s) and inducing replication-
associated DNA double-strand breaks (DSBs). In this 
paper, we propose a new mechanism by which cells avoid 
Top1-induced replication-dependent DNA damage. We 
show that the structure-specific endonuclease Mus81-Eme1 
is responsible for generating DSBs in response to Top1 in-
hibition and for allowing cell survival. We provide evi-
dence  that  Mus81  cleaves  replication  forks  rather  than 
excises Top1cc’s. DNA combing demonstrated that Mus81 
also allows efficient replication fork progression after CPT 
treatment. We propose that Mus81 cleaves stalled replica-
tion forks, which allows dissipation of the excessive super-
coiling resulting from Top1 inhibition, spontaneous reversal 
of Top1cc, and replication fork progression.
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stalling in the absence of RecQ helicases (Kaliraman et al., 
2001; Mullen et al., 2001; Doe et al., 2002; Trowbridge et al., 
2007; Franchitto et al., 2008; Shimura et al., 2008). Mus81 is 
also required for the proper completion of homologous recom-
bination, both during meiosis (Smith et al., 2003; Jessop and 
Lichten, 2008; Oh et al., 2008) and mitosis (Blais et al., 2004; 
Roseaulin et al., 2008).
In the present study, we explore the role of Mus81 in the 
cellular response of human cells to Top1 inhibitors. We show 
that Mus81 is not involved in the direct excision of Top1cc but 
rather participates in the repair and recovery of damaged repli-
cation forks by incision of the stalled replication forks.
Results
Mus81-deficient cells are hypersensitive  
to CPT
To assess the potential role of Mus81 in the cellular responses 
to Top1 inhibitors, we compared survival of wild-type (WT) 
and Mus81-deficient (Mus81
/) human HCT116 colon carci-
noma cells (Fig. 1 A) after CPT treatment (Holm et al., 1989). 
Cells were exposed to CPT for 1 h, and CPT sensitivity was   
assessed by clonogenic survival assays. Fig. 1 B shows that 
Mus81-deficient cells are significantly more sensitive than WT 
cells to pharmacological concentrations (0.01, 0.1, and 1 µM) of 
CPT, which selectively target replicating cells (Huang et al., 
2010). At high concentrations of CPT (10 µM), which exceed 
those achieved in cancer therapy and for which cell lethality is 
primarily related to transcription-induced damage (Sordet et al., 
2009; Zhang et al., 2011), >98% of the WT cells were killed, 
and the impact of Mus81 knockdown was minimal (Fig. 1 B). 
These results demonstrate the involvement of Mus81 in the 
cellular response to Top1 inhibitors under conditions in which 
Top1 inhibitors primarily target S-phase cells.
To investigate whether the hypersensitivity of Mus81
/ 
cells resulted from an enrichment in S-phase cells, we deter-
mined the cell cycle distributions of WT and Mus81
/ cells 
by BrdU incorporation assays. WT and Mus81
/ cells showed 
similar cell cycle profiles, both in the absence and presence of 
1 µM CPT for 1 h (Fig. 1 C). Thus, Mus81 deficiency did not 
result in a higher proportion of S-phase cells, which excludes 
the possibility that more cells in S phase could account for the 
increased sensitivity to CPT.
Mus81 does not excise Top1cc’s
Because Mus81-Eme1 is a 3 flap endonuclease, it has been 
postulated that it would cleave 5 from the Top1cc and partici-
pate in the excision of trapped Top1 from the DNA (Liu et al., 
2002; Vance and Wilson, 2002; Deng et al., 2005). To deter-
mine whether Mus81 is involved in Top1cc removal, we ana-
lyzed the formation of Top1cc’s in WT and Mus81
/ cells 
treated with various CPT concentrations. Top1cc’s were de-
tected by Western blotting of cellular DNA fractions with an 
anti-Top1 antibody (Miao et al., 2006; Zhang et al., 2011). Top1cc 
levels were similar in WT and Mus81
/ cells upon CPT treat-
ment (Fig. 2, A and B). In addition, Top1cc reversed efficiently 
in both WT and Mus81
/ cells after CPT removal (Fig. 2 B). 
converts collapsed replication forks into DNA double-strand 
breaks (DSBs; Hanada et al., 2006, 2007; Franchitto et al., 
2008; Froget et al., 2008; Shimura et al., 2008) and is con-
sidered a back-up system for the resolution of replication fork 
Figure 1.  Mus81-deficient cells are hypersensitive to CPT. (A) Western 
blotting  analysis  of  Mus81  expression  in  WT  and  Mus81
/  HCT116 
cells. Actin was used as a loading control. (B) Mus81 deficiency decreases 
survival of HCT116 cells after CPT exposure. Cells were treated with the 
indicated concentrations of CPT for 1 h and cultured 13 d to allow colony 
formation. The surviving fraction of untreated cells was defined as 100%. 
Mean values ± SEM from six independent experiments are shown. *, P <   
0.05; **, P < 0.01; Mann–Whitney test. (C) Cell cycle profiles of un-
treated or CPT-treated WT and Mus81
/ cells. Cells were incubated with 
1 µM CPT for 1 h and were pulse labeled with BrdU during the last 10 min. 
The x axis shows DNA content, and the y axis shows BrdU incorporation. 
Boxed dotted lines and percentages indicate S-phase cell subpopulations.741 Resolution of stalled replication forks by Mus81 • Regairaz et al.
Figure 2.  Mus81-deficient cells are not defective in the removal of Top1cc. (A–C) Top1 trapping and reversal are similar in WT and Mus81
/ cells.   
(A) Top1cc levels in WT and Mus81
/ HCT116 cells treated with the indicated concentrations of CPT for 1 h. Data from three independent experiments are 
shown. (B) Detection of Top1cc in WT and Mus81
/ HCT116 cells treated with 1 µM CPT for 1 h. R30’, cells were harvested 30 min after CPT removal. 
Different concentrations of genomic DNA (5, 2.5, and 1.25 µg) were probed with an anti-Top1 antibody. (left) Representative experiment. Dashed lines 
indicate that intervening wells have been spliced out. (right) Quantification of Top1cc (n = 3). (A and B, right) Dashed lines indicate Top1cc levels in WT 
untreated cells. (C) Measurement of DNA–Top1 cross-links by alkaline elution in WT and Mus81
/ cells treated with 1 µM CPT for 1 h. R30’ and R60’, 
cells were harvested 30 and 60 min after CPT removal. (left) Representative alkaline elution experiment. (right) Quantification of DNA–Top1 cross-linking 
(in rad equivalents [rad-eq]; Covey et al., 1989). Data from four independent experiments are shown. Mean values ± SEM are shown. A.U., arbitrary 
unit; Ctrl, control.
Consistent with these results, Mus81 silencing in MDA-MB-231 
breast cancer cells did not impair the formation or reversal of 
Top1cc in response to CPT (Fig. S1, A and B). Under the 
same experimental conditions, TDP1 silencing resulted in 
higher Top1cc levels, both during and after CPT treatment 
(Fig. S2; Miao et al., 2006).JCB • VOLUME 195 • NUMBER 5 • 2011   742
5-ethynyl-2-deoxyuridine  (EdU;  to  detect  replicating  cells) 
before and during CPT treatment. EdU and -H2AX costain-
ing showed that -H2AX was induced in both replicating (EdU 
positive) and nonreplicating (EdU negative) cells, with higher 
-H2AX levels being observed in the replicating cells (Fig. 4 A). 
Mus81 deficiency was associated with significantly lower -H2AX 
levels in replicating cells but did not affect -H2AX induction 
in nonreplicating cells (Fig. 4, A and B).
The occurrence of Mus81-dependent DNA breaks in rep-
licating cells is consistent with the cleavage of stalled DNA 
replication forks by Mus81 (see Introduction). To address this 
possibility,  we  performed  single-cell  analyses  of  EdU  and   
-H2AX foci. In WT cells treated with CPT, 68% of the repli-
cation foci (labeled with EdU) colocalized with -H2AX foci 
(Fig. 4, C and D; and Fig. S3, top), which is consistent with 
the preferential induction of DSBs by CPT in replication foci 
(Seiler et al., 2007). On the other hand, in Mus81-deficient cells, 
the fraction of damaged replication foci (i.e., those EdU foci 
colocalizing with -H2AX foci) was significantly decreased 
(39%; Fig. 4, C and D; and Fig. S3, bottom), and the frac-
tion of -H2AX foci outside the EdU foci was significantly 
increased (Fig. 4, C and E; and Fig. S3). These results indicate 
the selective induction of Mus81-dependent DSBs at replica-
tion foci.
Mus81 promotes replication fork 
progression after Top1 inhibition
To study the effects of Mus81 on replication fork progression, 
we analyzed replication in single DNA molecules using DNA 
combing (Conti et al., 2007; Seiler et al., 2007). Incorporation 
of the thymidine analogues iododeoxyuridine (IdU) and chloro-
deoxyuridine (CldU) was visualized on stretched DNA fibers 
prepared  from  untreated  or  CPT-treated  WT  and  Mus81
/ 
cells. Cells were labeled with IdU and CldU for 30 min each, 
and CPT was added during the last 20 min of the IdU pulse 
(Fig. 5 A). This protocol allows the analysis of both replication 
fork slow down (by comparing replication fork velocity in the 
presence and in the absence of CPT) and replication fork recov-
ery (by comparing fork velocity during CPT treatment and after 
CPT removal). In both WT and Mus81
/ cells, CPT induced a 
marked reduction in replication fork velocity (Fig. 5, B and C;   
and Fig. S4). After CPT removal, CldU incorporation was mea-
sured in both WT and Mus81
/ cells (Fig. 5, B and C). In WT 
cells, replication fork velocity resumed to 50% of its mean 
value before CPT (Fig. 5 B, left), whereas, in Mus81
/ cells, 
there was no detectable recovery upon CPT removal (Fig. 5 B, 
right). These results show that Mus81 is associated with recov-
ery of replication fork velocity after CPT removal.
Discussion
CPT and its clinically used derivatives topotecan and irino-
tecan  are  primarily  cytotoxic  to  S-phase  cells  at  pharma-
cological concentrations (Holm et al., 1989; Hsiang et al., 
1989), as they induce replication-associated DSBs that are 
primarily processed by homologous recombination (Eng et al., 
1988;  Nitiss  and  Wang,  1988;  Vance  and  Wilson,  2002;   
Alkaline elution assays were used to detect Top1cc’s as 
DNA–protein cross-links (DPCs; Miao et al., 2006) in WT and 
Mus81
/ cells treated with CPT. DPCs formed similarly in 
WT and Mus81
/ cells (Fig. 2 C, left, top curves). 30 min 
after CPT removal, reversal of DPC was partial but was not 
significantly different in WT and Mus81
/ cells (Fig. 2 C). 
DPCs fully reversed after 60 min in both WT and Mus81
/ 
cells (Fig. 2 C, right). Together, these results demonstrate that 
Mus81 is not involved in the excision of Top1 from the DNA.
Mus81 generates DNA DSBs in  
CPT-treated cells
To elucidate the role of Mus81 in the cellular response to Top1-
induced DNA damage, we next analyzed the influence of Mus81 
on  the  formation  of  Top1-induced  DNA  DSBs.  WT  and 
Mus81
/ cells were exposed to various concentrations of CPT 
for 1 h, and the DSB marker -H2AX (Rogakou et al., 1998; 
Furuta et al., 2003) was examined by immunofluorescence. 
CPT-induced -H2AX levels were greatly reduced in Mus81-
deficient cells (Fig. 3 A), indicating that Mus81 is involved in 
the formation of DSBs in CPT-treated cells. This result was fur-
ther supported by neutral comet assays showing that Mus81
/ 
cells accumulated less DSBs than WT cells in response to CPT 
(Fig. 3 B). Time-course analysis showed reduced -H2AX in-
duction in Mus81-deficient cells at both short and long time 
points after CPT treatment (Fig. 3 C).
Mus81
/ cells also demonstrated a lower and delayed in-
duction of other DNA damage response signals in response to 
CPT, including phosphorylation of Chk2 at threonine 68 (ATM 
[ataxia telangiectasia mutated] substrate) and phosphorylation 
of RPA2 (Fig. 3 C). However, phosphorylation of Chk1 at 
serine  317  (ATR  [ataxia  telangiectasia  and  Rad3  related] 
substrate) was induced similarly in Mus81
/ and WT cells upon 
CPT treatment, indicating reduced DSBs but efficient activation 
of the replication checkpoint in Mus81
/ cells (Fig. 3 C).
siRNA-mediated  depletion  of  Mus81  in  MDA-MB-231 
cells also resulted in a marked reduction of CPT-induced   
-H2AX (Fig. S1, C and D). As Mus81 functions as a hetero-
dimer with Eme1 (Ciccia et al., 2008), we measured -H2AX 
induction upon CPT exposure in HCT116 cells transfected with 
Eme1-targeting siRNAs. Eme1 silencing resulted in a marked 
reduction in CPT-induced -H2AX, recapitulating the pheno-
type of Mus81
/ cells (Fig. S1 E). Collectively, these results 
demonstrate that Mus81 is involved in the formation of DSBs 
in CPT-treated cells.
Mus81-dependent DNA DSBs form at 
replication foci
CPT-induced DSBs result from interference of stabilized Top1cc 
with either replication or transcription machineries (Hsiang   
et al., 1989; Ryan et al., 1991; Strumberg et al., 2000; Pommier   
et al., 2006; Sordet et al., 2009). To investigate whether Mus81-
dependent DNA breaks are related to replication (Seiler et al., 
2007) or transcription (Sordet et al., 2009; Zhang et al., 2011) 
in CPT-treated cells, we next analyzed -H2AX induction in 
replicating and nonreplicating cell subpopulations. WT and 
Mus81
/ cells were labeled with the thymidine analogue   743 Resolution of stalled replication forks by Mus81 • Regairaz et al.
Mus81 inactivation either by stable knockout (Hiyama et al., 
2006) or siRNA reduces CPT-induced DSBs selectively in rep-
licating cells and at replication foci (Fig. 4). Our conclusion 
is consistent with the known biochemical activities of Mus81-
Eme1, which preferentially processes substrates mimicking rep-
lication forks (Kaliraman et al., 2001; Doe et al., 2002; Fricke 
et al., 2005; Ehmsen and Heyer, 2008). The Mus81-dependent 
DSBs are not lethal but are associated with DNA repair. Indeed, 
inactivation of Mus81 results in more cell killing (Fig. 1 B) and 
Hochegger et al., 2006; Nakamura et al., 2010). At least some 
of those DSBs have been shown to result from the conversion 
of Top1-associated single-strand breaks into DSBs by replica-
tion runoff (Fig. 6 A; Hsiang et al., 1989; Tsao et al., 1993; 
Shao et al., 1999; Strumberg et al., 2000).
Our study proposes an alternative by showing that the 
structure-specific endonuclease Mus81-Eme1 is responsible for 
the generation of DSBs at stalled replication forks in response 
to Top1 trapping. This conclusion is based on our findings that 
Figure 3.  Mus81-dependent induction of DNA DSBs and DNA damage response in CPT-treated cells. (A) Immunostaining analysis of -H2AX induction 
in WT and Mus81
/ cells treated with the indicated concentrations of CPT for 1 h. (left) Representative microscopy images. Circles indicate nuclear 
contours. (right) Quantification of -H2AX fluorescence per cell. Fluorescence signals were scored in 60 cells per sample. (B) DNA DSBs measured by 
neutral comet assay in WT and Mus81
/ HCT116 cells treated with 1 µM CPT for 1 h. (left) Representative comet images. (right) Quantification of comet 
tail moments. At least 50 cells per sample were scored. (C) DNA damage response (phospho-H2AX (-H2AX), phospho [P]-Chk2, -RPA2, and -Chk1) in 
WT and Mus81
/ HCT116 cells treated with 1 µM CPT. GAPDH was used as a loading control. Mean values ± SEM are shown. **, P < 0.001; ***,   
P < 0.0001; Mann–Whitney test. Ctrl, control.JCB • VOLUME 195 • NUMBER 5 • 2011   744
Figure 4.  Mus81-dependent DNA DSBs form at replication foci. Replication factories were labeled with EdU for 90 min. 1 µM CPT was added during the 
last 60 min. (A and B) Analysis of CPT-induced -H2AX in replicating (EdU positive) or nonreplicating (EdU negative) WT or Mus81
/ cells. (A) Represen-
tative microscopy images showing Mus81-dependent -H2AX response in replicating cells. (B) Quantification of -H2AX fluorescence signals in individual 
cells. 90–100 cells were scored per sample. Each dot represents a single cell. Mean values ± SEM are shown in red. Dotted lines indicate -H2AX mean 
levels in untreated cells. (C) Representative microscopy images showing the colocalization of EdU and -H2AX foci in EdU-positive cells. (right) Magnified 
images of squared areas from left images. (D and E) Detailed analysis of EdU and -H2AX colocalization in EdU-positive cells demonstrating that Mus81 
is involved in -H2AX formation at replication foci. (D) Percentages of replication foci colocalized with -H2AX (defined as 100% x [number of EdU foci 
colocalizing with -H2AX foci divided by the total number of EdU foci]). (E) Percentages of -H2AX foci outside replication foci (defined as 100% x [number 
of -H2AX foci that do not colocalize with EdU foci divided by the total number of -H2AX foci]). 20 individual cells were scored per sample. Mean percent-
ages ± SD are shown. **, P < 0.005; ***, P < 0.0001; Student’s t test. Blue, DAPI nuclear staining; red, EdU; green, -H2AX. A.U., arbitrary unit.745 Resolution of stalled replication forks by Mus81 • Regairaz et al.
involvement of Mus81 in the formation of replication-associated 
DSBs after CPT treatment rather than in the direct excision 
of Top1 from the DNA. Our findings are best explained by the 
possibility that Top1 inhibition leads to replication fork stall-
ing, which is resolved by Mus81-dependent DNA cleavage 
(Fig. 6, B–H). This interpretation is consistent with an indepen-
dent publication proposing that Top1 inhibition by CPT in yeast 
less DSBs (Figs. 3 and 4). Mus81-dependent DNA breakage 
has  also  been  observed  in  mammalian  cells  upon  treatment 
with cisplatin (Hanada et al., 2006) and with the replication 
fork-blocking drugs aphidicolin and hydroxyurea (Hanada   
et al., 2007; Franchitto et al., 2008; Froget et al., 2008; Shimura 
et al., 2008). These studies have established that Mus81 can 
convert a stalled replication fork into a DSB. Here, we show the   
Figure 5.  Mus81 promotes efficient replication fork progression. (A) Experimental protocol. Cells were labeled sequentially with IdU and CldU for 30 min 
each. 1 µM CPT was added during the last 20 min of the IdU pulse. IdU and CldU were detected on combed DNA fibers using specific antibodies in green 
and red, respectively. W, wash. (B) Analysis of replication forks during and after CPT exposure, demonstrating efficient replication fork recovery in WT 
but not in Mus81
/ cells. At least 160 green/red replication signals were measured per sample. Each dot represents a single replication signal. Mean 
values ± SEM are shown in black. P-values were calculated using the Student’s t test. n, number of replication signals measured. (C) Representative images and 
schematic drawings of replication signals detected on DNA fibers. Ctrl, control.JCB • VOLUME 195 • NUMBER 5 • 2011   746
that Top1 may be particularly important in highly transcribed 
regions (Christman et al., 1993). In mammalian cells, Top1 de-
ficiency leads to an accumulation of stalled replication forks 
and DNA breakage at replication sites (Miao et al., 2007; 
Tuduri et al., 2009). Because Top1 is required for efficient DNA 
relaxation during replication (Kim and Wang, 1989; Koster   
et al., 2007), Top1-deficient cells probably accumulate un-
resolved supercoiling in replicating DNA, which further leads 
to replication fork stalling and breakage.
We also show that Mus81 is required for efficient replica-
tion fork progression after CPT removal. Parallel observations 
have been made in cells treated with hydroxyurea or aphidicolin 
(Hanada  et  al.,  2007;  Shimura  et  al.,  2008),  indicating  that 
Mus81-induced DSBs act as resolution intermediates for repli-
cation fork recovery. DSBs arising during replication are re-
paired primarily by homologous recombination (Takata et al., 
1998; Arnaudeau et al., 2001; Rothkamm et al., 2003; Sonoda 
et al., 2006). Thus, Mus81-dependent DSBs could support strand 
invasion and initiate sister chromatid exchange. Mus81 is also 
required for the resolution of Holliday junctions (Blais et al., 
2004; Fricke et al., 2005; Ehmsen and Heyer, 2008; Jessop and 
leads to supercoiling accumulation ahead of replication forks, 
leading to replication fork stalling (Koster et al., 2007).
Because Mus81 is responsible for only a fraction of the 
replication-associated DSBs after Top1 inhibition (Fig. 4, C 
and D), it is plausible that Top1-mediated replication-associated 
DSBs  are  produced  both  by  Mus81-dependent  and  Mus81- 
independent mechanisms. Thus, it is likely that Top1 trapping 
induces replication-associated DSBs either by replication runoff 
(Fig. 6 A) or by Mus81-dependent cleavage of replication forks 
stalled by positive supercoils (Fig. 6 C). Replication fork cleav-
age by Mus81-Eme1 could allow the dissipation of the exces-
sive superhelical tension (Fig. 6, C and D), which could resolve 
the topological block resulting from Top1 deficiency ahead of 
the fork. This hypothesis is supported by genetic experiments 
in yeast, showing that mutations in both Mus81 and Mms4
Eme1 
results in growth defects in top1 strains (Mullen et al., 2001). 
It is also supported by the recent findings that Top1 deficiency 
in yeast, murine, and human cells is associated with genomic 
instability (Christman et al., 1993; Miao et al., 2007; Tuduri   
et al., 2009). Top1 deficiency in yeast is associated with enhanced 
genomic instability in the ribosomal DNA cluster, suggesting 
Figure  6.  Model  for  the  processing  of  stalled 
replication  forks  by  Mus81-Eme1.  (A)  Classi-
cal  model  illustrating  Mus81-independent  in-
duction  of  replication-associated  DNA  DSE  by 
replication fork runoff (Strumberg et al., 2000).   
(B–H)  Novel  model  showing  Mus81-mediated 
DSBs. A Top1cc on the leading strand is shown, 
but  the  same  would  apply  if  the  Top1cc  was 
on  the  lagging  strand.  (B)  Top1  trapping  by 
CPT  (green  rectangle)  results  in  the  accumula-
tion of positive supercoiling (Sc+), which stalls 
the replication fork. Purple triangle, DNA poly-
merase complex. (C) Cleavage of the stalled fork 
by Mus81-Eme1. (D) Cleavage of the template 
DNA allows supercoiling relaxation and 5-end 
exonucleolytic  resection.  (E)  After  spontaneous 
dissociation of CPT, Top1cc’s reverse, and the 
newly synthesized strands hybridize, forming a 
“chicken foot”; alternatively, the fork cleaved by 
Mus81 can be processed by homologous recom-
bination. (F) Annealing of the template strands. 
(G) Gap filling by DNA polymerase. (H) Fork 
reestablishment and replication restart.747 Resolution of stalled replication forks by Mus81 • Regairaz et al.
Detection of Top1cc’s
After drug treatment, cells were lysed in a reagent (DNAzol; Invitrogen), 
and genomic DNA was prepared according to the manufacturer’s instruc-
tions. Samples were sonicated briefly to shear the DNA. Varying concentra-
tions of DNA were spotted on transfer membranes (Immobilon-FL; Millipore) 
using a slot-blot manifold (GE Healthcare). Membranes were blocked in 
blocking buffer (Odyssey; LI-COR Biosciences) and incubated successively 
with a C21 anti-Top1 antibody (gift from Y.-C. Cheng, Yale University, 
New Haven, CT) and with the goat anti–mouse secondary antibody (IRDye 
800CW; LI-COR Biosciences). Both antibodies were diluted in blocking 
buffer. Membranes were imaged with the Odyssey Infrared Imaging Sys-
tem (LI-COR Biosciences).
Immunofluorescence
For immunofluorescence assays, cells were grown in chamber slides (Lab-
Tek; Thermo Fisher Scientific). The staining for -H2AX was performed as 
previously described (Zhang et al., 2011). After drug treatment, cells were 
fixed and permeabilized by a 20-min incubation at room temperature in 
2% paraformaldehyde and an overnight incubation at 4°C in 70% ethanol. 
Slides were blocked in 8% bovine serum albumin and stained successively 
with anti–-H2AX antibody (Abcam) and with a fluorescent secondary 
antibody (anti–mouse Alexa Fluor 488; Invitrogen). Both antibodies were 
diluted in 1% bovine serum albumin. Slides were mounted in mounting 
medium containing DAPI (Vectashield; Vector Laboratories) and visualized 
using a confocal microscope (Eclipse TE300; Nikon). Fluorescent signals in 
individual cells were quantified using Photoshop CS5 (Adobe).
For the simultaneous detection of -H2AX and replication foci, cells 
were labeled with 30 µM EdU for 90 min. 1 µM CPT was added dur-
ing the last 60 min of the EdU pulse. -H2AX staining was performed as 
described in the previous paragraph, and EdU was detected with a flow 
cytometry assay kit (Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay; 
Invitrogen) according to the manufacturer’s instructions. Confocal images 
were sequentially acquired with ZEN (2009, SP1; Carl Zeiss) software on 
a confocal system (LSM 510; Carl Zeiss) with an inverted microscope (Axio 
Observer.Z1; Carl Zeiss) and a UV laser tuned to 364 nm, a 25-mW argon 
visible laser tuned to 488 nm, and a 5-mW HeNe laser tuned to 633 nm.   
A 63× Plan Apochromat 1.4 NA oil immersion objective was used. Emis-
sion signals after sequential excitation of DAPI, Alexa Fluor 488, and Alexa   
Fluor 633 by the 364-, 488-, or 633-nm laser lines were collected with a 
band pass 385–470, band pass 505–550, or long pass 650 filter, respec-
tively, using individual photomultipliers. Images were acquired at room 
temperature, and the mounting medium was Vectashield with DAPI. Images 
were adjusted using Photoshop and combined using Illustrator (Adobe).
Neutral comet assay
DNA DSBs were detected using the neutral comet assay according to the 
gel  electrophoresis  kit  protocol  (CometAssay;  Trevigen;  Zhang  et  al., 
2008). Comet tail moments were measured with CometScore 1.5 software 
(TriTek Corporation).
Western blotting
Whole-cell extracts were obtained by homogenization of cell pellets in 
lysis buffer (1% SDS and 10 mM Tris-HCl, pH 7.4) supplemented with 
proteases and phosphatases inhibitors (Roche). Proteins were separated 
by SDS-PAGE electrophoresis and immunoblotted with the following anti-
bodies: anti-Mus81 (Abcam), anti–-H2AX, antiphospho-RPA2 (S4/8; 
Novus Biologicals), antiphospho-Chk1 (S317), antiphospho-Chk2 (T68), 
anti–glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Cell Signaling 
Technology), and anti–-actin (Sigma-Aldrich).
siRNA transfection
Cells seeded in 6-well plates or LabTek chambers were transfected with 
targeting or nontargeting siRNAs using transfection reagent (Dharma-
FECT; Thermo Fisher Scientific). Mus81-targeting, Eme1-targeting, and 
nontargeting siRNAs were products of Thermo Fisher Scientific. TDP1-
targeting siRNAs were purchased from QIAGEN.
DNA replication profiling by molecular combing
Molecular combing was performed as previously described (Conti et al., 
2007; Seiler et al., 2007). In brief, asynchronous exponentially growing 
cells were labeled sequentially with the thymidine analogues IdU and CldU 
for 30 min each. To study replication fork arrest and restart, 1 µM CPT was   
added during the last 20 min of the IdU pulse. At the end of the CldU pulse, 
cells were harvested by trypsinization and embedded in low-melting agarose 
plugs. Agarose plugs were treated with proteinase K and then melted at 
70°C in the presence of 4-morpholinepropanesulfonic acid, pH 6.5. 
Lichten, 2008; Oh et al., 2008; Roseaulin et al., 2008) and could 
therefore participate in both initiation and completion of homol-
ogous recombination during S phase (Fig. 6 E). Alternatively, 
Mus81-dependent fork cleavage could enable replication pro-
gression by allowing retraction of the replication machinery 
(Fig. 6, D–H), possibly in association with the Bloom helicase. 
After nucleolytic resection of the 5 end of the DNA, annealing 
of the two newly synthesized DNA strands would initiate repli-
cation fork regression, allowing reannealing of the two parental 
DNA strands and gap filling by DNA polymerase.
In conclusion, our study demonstrates that the Mus81-
Eme1 endonuclease is involved in the repair of Top1-mediated 
DNA damage by promoting the cleavage and restoration of 
stalled replication forks. This mechanism may not be limited 
to CPT-induced DNA damage, as Top1 can be trapped by a 
variety of endogenous DNA lesions, such as oxidized bases, 
mismatches, abasic sites, adducts, and strand breaks (Pourquier 
and Pommier, 2001; Pommier et al., 2006; Dexheimer et al., 
2008b). Mus81 is therefore a novel and important determi-
nant of the cellular response of cancer cells to Top1 inhibi-
tors  and  replication  fork  stalling  by  Top1  deficiency  and 
excessive supercoiling.
Materials and methods
Cell lines and drugs
Human MDA-MB-231 breast adenocarcinoma cells were obtained from 
the Developmental Therapeutics Program (National Cancer Institute) and 
were maintained in RPMI 1640 supplemented with 10% fetal bovine   
serum. Human HCT116 colorectal carcinoma cells and HCT116 Mus81
/ 
cells (Hiyama et al., 2006) were grown in DME supplemented with 10% 
fetal bovine serum. CPT was obtained from the Drug Synthesis and Chem-
istry Branch (National Cancer Institute).
Clonogenic survival assay
After drug treatment, cells were seeded in 6-well plates at a density of 50, 
250, or 500 cells/well and incubated for 10–13 d to allow colony forma-
tion. Colonies were fixed with methanol and stained with 0.05% methylene 
blue (Sigma-Aldrich) for 30 min. The surviving fraction was calculated by 
dividing the number of colonies in treated wells by the number of colonies 
in untreated wells.
Alkaline elution assays
DPCs were detected using alkaline elution as previously described (Covey 
et al., 1989). In brief, cells were radiolabeled overnight with 0.02 µCi/ml 
[
14C]thymidine and chased with radioisotope-free medium 4 h before drug 
treatment. Cell aliquots were placed in ice-cold HBSS and irradiated with 
30 grays to break the DNA. Cells were layered onto polyvinylchloride-
acrylic copolymer (protein adsorbing) filters and lysed with LS-10 (2 M 
NaCl, 0.2% sarkosyl, and 0.04 M disodium EDTA, pH 10). DNA was 
eluted from the filters with tetrapropylammonium hydroxide-EDTA. After 
elution, filters were incubated for 1 h at 65°C with 1 M HCl and an addi-
tional hour at room temperature in the presence of 0.3 M NaCl. Radio-
activity  in  fractions  and  filters  was  measured  with  a  liquid  scintillation 
analyzer (2200A Tri Carb Scintillation Analyzer; Packard Instruments).
BrdU incorporation assay
Cells were pulse labeled with 50 µM BrdU (EMD) during the last 10 min of 
CPT treatment. Cells were harvested by trypsinization, fixed in 70% ice-
cold ethanol, and stored at 20°C. Cells were incubated for 30 min at 
room temperature in 2 N HCl–0.5% Triton X-100 to allow DNA denatur-
ation. The medium was neutralized in 0.1 M sodium borate, pH 8.5, and 
cells were washed twice in PBS containing 0.5% Tween 20 and 0.5% bo-
vine serum albumin. Cells were incubated for 1 h at room temperature with 
an FITC-conjugated anti-BrdU antibody (BD) and were treated with 0.5 
mg/ml RNase A and 50 µg/ml propidium iodide. Samples were analyzed 
with a flow cytometer (FACScan; BD) using the CellQuest software (BD).JCB • VOLUME 195 • NUMBER 5 • 2011   748
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Surfaces, Inc.). DNA fibers were denatured in 0.5 M NaOH and probed 
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thiocyanate (IdU specific; BD) and rat anti-BrdU (CldU specific; Accurate 
Chemical and Scientific Corp.). After labeling with fluorescent secondary 
antibodies (anti–mouse Alexa Fluor 488 and anti–rat Alexa Fluor 594; 
Invitrogen), slides were mounted in Vectashield mounting medium. Images 
were captured with the AttoVision software (BD) using an epifluorescence 
microscope (Pathway; BD). Replication signals were measured using ImageJ 
(National Institutes of Health) with custom-made modifications. Measure-
ments were converted from micrometers to kilobases according to a con-
stant stretching factor (1 µm = 2 kb). Fork velocities were calculated by 
dividing the length of a replication signal (in kilobases) by the labeling 
time (in minutes).
Statistical analyses
All results are presented as means ± SEM or SD. Differences between sam-
ples were assessed using the Mann–Whitney test or the Student’s t test, de-
pending on the distribution of the sample. The normal distribution of a 
sample was tested with the Kolmogorov–Smirnov test. All analyses were 
conducted with Prism 5.0 (GraphPad Software). P-values were two sided 
and considered statistically significant when <0.05.
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